Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC)

Lung Cancer(2021)10.1016/j.lungcan.2021.08.010Source: DataRank Database

Impact of XPO1 mutations on survival outcomes in metastatic non-small cell lung cancer (NSCLC) is a research paper published in Lung Cancer (2021). On theSindex it has a DataRank of 0.416. It has been cited 15 times.

N/A

0.416DataRank · unranked

Scored on demand from live citation data

Open Access15 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 0.67)OA: hybridTopics (56)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

DataRank Breakdown

Base Score 100%Citation Network 0%

Base Score Contribution

0.416

From this paper's citation signal

Citation Network Contribution

Citation network not refreshed for this result

This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.

Learn more about DataRank methodology →

Authors (23)

Mohammad Asad ORCID,Mohammed Najeeb Al Hallak ORCID,Md. Hafiz Uddin ORCID,Ammar Sukari ORCID,Yasmine Baca ORCID

Live enrichment

PubMed:34482103 PMC:PMC8853639 OpenAlex:https://openalex.org/W3196552044

National Cancer Institute

Grant: R37-CA215427

NCI NIH HHS

Grant: P30 CA022453

NCI NIH HHS

Grant: R37 CA215427

National Institutes of Health

Grant: 5R37CA215427-04

Clinical Translation of Nuclear Export Inhibitor in Metastatic Pancreatic Cancer

FWCI

0.67

Citation Percentile

0.7%

Citation Trend

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1016/j.lungcan.2021.08.010

publisherhttps://doi.org/10.1016/j.lungcan.2021.08.010

publisherhttps://api.elsevier.com/content/article/PII:S0169500221005110?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0169500221005110?httpAccept=text/plain

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34482103

Fields of Study

Nuclear Structure and FunctionGenetic factors in colorectal cancerCell death mechanisms and regulation0301 basic medicine0303 health sciences03 medical and health sciencesCarcinoma, Non-Small-Cell LungHumansKaryopherinsLung NeoplasmsMutationReceptors, Cytoplasmic and NuclearExportin 1 Protein

MeSH Terms

Exportin 1 ProteinCarcinoma, Non-Small-Cell LungHumansLung NeoplasmsMutationReceptors, Cytoplasmic and NuclearKaryopherins

Keywords

KRASMedicineLung cancerOncologyCancerInternal medicineMutationHazard ratioImmunohistochemistryCancer researchSurvival analysisCDKN2ATranscriptomeGeneAdenocarcinomaBiologyGeneticsGene expressionColorectal cancerConfidence intervalNSCLCNgsXpo1Nuclear Protein TransportTumor Mutational BurdenLung NeoplasmsCytoplasmic and NuclearCarcinoma610Receptors, Cytoplasmic and NuclearExportin 1 ProteinKaryopherinsCarcinoma, Non-Small-Cell LungReceptorsHumansNon-Small-Cell Lung

Sustainable Development Goals

SDG 3: 3. Good health